BrightPath Biotherapeutics (4594) Income Statement & Earnings

59
+4+7.27%

20min DelayMarket Closed Jan 16 15:30 JST

6.57BMarket Cap-4.18P/E (Static)

BrightPath Biotherapeutics (4594) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2025

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

Total revenue

1,473.61%1.13M

-98.64%72K

-90.20%5K

-99.54%23K

-61.64%28K

-84.91%16K

-65.73%5.28M

-99.66%51K

7,437.31%5.05M

43.14%73K

Cost of revenue

77.78%32K

-99.05%18K

-99.67%2K

-99.60%5K

-61.11%7K

-84.62%4K

-42.87%1.9M

-81.05%613K

7,182.35%1.24M

50.00%18K

Gross profit

1,938.89%1.1M

-98.40%54K

100.71%4K

-99.55%17K

-61.82%21K

-84.81%12K

-72.01%3.38M

-104.75%-562K

7,524.00%3.81M

44.74%55K

Operating expense

0.60%1.16B

-21.44%1.16B

-16.21%207.91M

-4.91%396.62M

-0.98%257.16M

-46.21%293.45M

-1.19%1.47B

-40.09%248.13M

18.40%417.12M

-18.57%259.7M

Operating profit

-0.51%-1.16B

21.27%-1.16B

16.40%-207.91M

4.04%-396.6M

0.97%-257.14M

46.20%-293.44M

0.61%-1.47B

38.19%-248.69M

-17.33%-413.3M

18.58%-259.64M

Net non-operating interest income (expenses)

-204.90%-4.23M

35.04%-1.39M

-1,598.78%-1.39M

101.35%6K

15.68%-2.14M

92.65%-82K

-991K

47.89%-445K

Non-operating interest income

475.00%69K

-40.00%12K

-33.33%6K

--0

----

-25.93%20K

-30.77%9K

--0

----

Non-operating interest expense

----

--0

----

-83.15%61K

----

Total other finance cost

207.22%4.3M

-33.19%1.4M

----

-4.69%2.09M

-96.09%30K

--991K

-47.47%456K

Net investment income

184.43%2.25M

44.86%-2.66M

-167.29%-2.15M

431.25%680K

67.17%-564K

74.22%-626K

-38.96%-4.82M

67.76%-804K

135.75%128K

-1,180.50%-1.72M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

81.12%-1.37M

27.17%-7.25M

74.97%-2.49M

-3.35M

-1.41M

-5,822.99%-9.96M

-1,088.88%-9.96M

Less:Write off

-81.12%1.37M

-27.17%7.25M

-74.97%2.49M

--3.35M

--0

--1.41M

74.67%9.96M

2,178.72%9.96M

--0

Other non-operating income (expenses)

7,564.29%15.02M

-18.67%196K

140.98%100K

-90K

-24.70%186K

170.79%241K

-244K

561.11%238K

Income before tax

1.45%-1.15B

21.40%-1.17B

17.68%-213.84M

3.57%-399.37M

1.48%-257.69M

46.14%-295.28M

-0.13%-1.48B

35.84%-259.78M

-16.95%-414.17M

18.34%-261.57M

Income tax

0.00%1.9M

0.00%475K

-21.49%1.9M

-21.49%475K

Net income

1.45%-1.15B

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

Net income continuous operations

1.45%-1.15B

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

Noncontrolling interests

Net income attributable to the company

1.45%-1.15B

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

1.45%-1.15B

21.37%-1.17B

17.65%-214.32M

3.57%-399.84M

1.48%-258.17M

46.10%-295.76M

-0.10%-1.49B

35.82%-260.25M

-16.88%-414.64M

18.35%-262.05M

Gross dividend payment

Basic earnings per share

22.46%-14.12

26.87%-18.21

23.06%-3.07

5.66%-6.33

7.64%-4.11

51.79%-4.7

12.78%-24.9

47.43%-3.99

0.74%-6.71

29.03%-4.45

Diluted earnings per share

22.46%-14.12

26.87%-18.21

25.81%-3.07

5.66%-6.33

7.64%-4.11

51.79%-4.7

12.78%-24.9

45.48%-4.1381

0.91%-6.71

29.03%-4.45

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2025	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022
Total revenue	1,473.61%1.13M	-98.64%72K	-90.20%5K	-99.54%23K	-61.64%28K	-84.91%16K	-65.73%5.28M	-99.66%51K	7,437.31%5.05M	43.14%73K
Cost of revenue	77.78%32K	-99.05%18K	-99.67%2K	-99.60%5K	-61.11%7K	-84.62%4K	-42.87%1.9M	-81.05%613K	7,182.35%1.24M	50.00%18K
Gross profit	1,938.89%1.1M	-98.40%54K	100.71%4K	-99.55%17K	-61.82%21K	-84.81%12K	-72.01%3.38M	-104.75%-562K	7,524.00%3.81M	44.74%55K
Operating expense	0.60%1.16B	-21.44%1.16B	-16.21%207.91M	-4.91%396.62M	-0.98%257.16M	-46.21%293.45M	-1.19%1.47B	-40.09%248.13M	18.40%417.12M	-18.57%259.7M
Operating profit	-0.51%-1.16B	21.27%-1.16B	16.40%-207.91M	4.04%-396.6M	0.97%-257.14M	46.20%-293.44M	0.61%-1.47B	38.19%-248.69M	-17.33%-413.3M	18.58%-259.64M
Net non-operating interest income (expenses)	-204.90%-4.23M	35.04%-1.39M	-1,598.78%-1.39M	0	101.35%6K	0	15.68%-2.14M	92.65%-82K	-991K	47.89%-445K
Non-operating interest income	475.00%69K	-40.00%12K	-33.33%6K	--0	----	----	-25.93%20K	-30.77%9K	--0	----
Non-operating interest expense	----	--0	----	----	----	----	-83.15%61K	----	----	----
Total other finance cost	207.22%4.3M	-33.19%1.4M	----	----	----	----	-4.69%2.09M	-96.09%30K	--991K	-47.47%456K
Net investment income	184.43%2.25M	44.86%-2.66M	-167.29%-2.15M	431.25%680K	67.17%-564K	74.22%-626K	-38.96%-4.82M	67.76%-804K	135.75%128K	-1,180.50%-1.72M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)	81.12%-1.37M	27.17%-7.25M	74.97%-2.49M	-3.35M	0	-1.41M	-5,822.99%-9.96M	-1,088.88%-9.96M	0	0
Less:Write off	-81.12%1.37M	-27.17%7.25M	-74.97%2.49M	--3.35M	--0	--1.41M	74.67%9.96M	2,178.72%9.96M	--0	--0
Other non-operating income (expenses)	7,564.29%15.02M	-18.67%196K	140.98%100K	-90K	0	-24.70%186K	170.79%241K	-244K	0	561.11%238K
Income before tax	1.45%-1.15B	21.40%-1.17B	17.68%-213.84M	3.57%-399.37M	1.48%-257.69M	46.14%-295.28M	-0.13%-1.48B	35.84%-259.78M	-16.95%-414.17M	18.34%-261.57M
Income tax	0.00%1.9M	0.00%1.9M	0.00%475K	0.00%475K	0.00%475K	0.00%475K	-21.49%1.9M	-21.49%475K	-21.49%475K	-21.49%475K
Net income	1.45%-1.15B	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M
Net income continuous operations	1.45%-1.15B	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M
Noncontrolling interests
Net income attributable to the company	1.45%-1.15B	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	1.45%-1.15B	21.37%-1.17B	17.65%-214.32M	3.57%-399.84M	1.48%-258.17M	46.10%-295.76M	-0.10%-1.49B	35.82%-260.25M	-16.88%-414.64M	18.35%-262.05M
Gross dividend payment
Basic earnings per share	22.46%-14.12	26.87%-18.21	23.06%-3.07	5.66%-6.33	7.64%-4.11	51.79%-4.7	12.78%-24.9	47.43%-3.99	0.74%-6.71	29.03%-4.45
Diluted earnings per share	22.46%-14.12	26.87%-18.21	25.81%-3.07	5.66%-6.33	7.64%-4.11	51.79%-4.7	12.78%-24.9	45.48%-4.1381	0.91%-6.71	29.03%-4.45
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"